• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国成功行导管消融术治疗心房颤动患者的长期随访期间的缺血性卒中风险。

Ischemic stroke risk during long-term follow up in patients with successful catheter ablation for atrial fibrillation in Korea.

机构信息

Division of Cardiology, Department of Internal Medicine, Korea University College of Medicine, Korea University Medical Center, Seoul, Republic of Korea.

Division of Cardiology, Chungbuk National University Hospital, Cheongju, Korea.

出版信息

PLoS One. 2018 Jul 19;13(7):e0201061. doi: 10.1371/journal.pone.0201061. eCollection 2018.

DOI:10.1371/journal.pone.0201061
PMID:30024976
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6053230/
Abstract

The interruption of oral anticoagulation therapy (OAC) after CA of atrial fibrillation (AF) is controversial. The purpose of this study was to evaluate the relationship between successful long-term outcomes of catheter resection and SR maintenance and ischemic stroke risk in Korea. We studied 1,548 consecutive patients who were followed up for more than 2 years after CA of AF. We investigated the incidence of ischemic stroke during long-term follow-up. Compared to the AF recurrence group (n = 619), the sinus rhythm (SR) maintenance group (n = 929) had more paroxysmal AF (74.6% versus 44.4%, p<0.001), smaller LA size (39.9±5.7mm versus 42.3±6.0mm, p<0.001), and younger age (54.2±10.9 years versus 56.4±10.6 years, p<0.001). However, CHA2DS2-VASc scores were not significantly different between the two groups (0.9 vs. 1.1, p = 0.053). The overall incidence of ischemic stroke during the mean follow-up period of 54 months after CA was 0.6%, and was significantly lower in the SR group than the AF recurrence group (0.3% vs. 1.1%, log-rank test p<0.001). However, in sub-analysis in the SR group, the rate of ischemic stroke was significantly increasing in patients with a CHA2DS2-VASc score ≥ 4 compared to those with a CHA2DS2-VASc score < 4 (4.3% vs. 0.2%, log-rank test p<0.001). In conclusion, this long-term follow-up data in patients with AF who underwent successful CA showed that SR maintenance was correlated with a lower rate of ischemic stroke in Korea. However, it was only observed in patients with CHA2DS2-VASc score ≤3.

摘要

房颤导管消融(CA)后中断口服抗凝治疗(OAC)存在争议。本研究旨在评估导管消融后成功维持窦性心律(SR)与 SR 维持和缺血性卒中风险之间的关系,并在韩国人群中进行研究。我们研究了 1548 例连续房颤患者,这些患者在 CA 后随访时间超过 2 年。我们调查了长期随访期间缺血性卒中的发生率。与房颤复发组(n = 619)相比,窦性心律维持组(n = 929)阵发性房颤更多(74.6% vs. 44.4%,p<0.001),左心房(LA)更小(39.9±5.7mm vs. 42.3±6.0mm,p<0.001),年龄更小(54.2±10.9 岁 vs. 56.4±10.6 岁,p<0.001)。然而,两组 CHA2DS2-VASc 评分无显著差异(0.9 vs. 1.1,p = 0.053)。CA 后平均 54 个月的随访期间,总体缺血性卒中发生率为 0.6%,SR 组明显低于房颤复发组(0.3% vs. 1.1%,log-rank 检验 p<0.001)。然而,在 SR 组的亚组分析中,CHA2DS2-VASc 评分≥4 分的患者缺血性卒中发生率明显高于 CHA2DS2-VASc 评分<4 分的患者(4.3% vs. 0.2%,log-rank 检验 p<0.001)。总之,这项在接受成功 CA 的房颤患者中进行的长期随访数据表明,在韩国,SR 维持与缺血性卒中发生率降低相关。然而,这仅在 CHA2DS2-VASc 评分≤3 的患者中观察到。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/056d/6053230/e66e8eefd353/pone.0201061.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/056d/6053230/2eeb5f5714bc/pone.0201061.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/056d/6053230/e66e8eefd353/pone.0201061.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/056d/6053230/2eeb5f5714bc/pone.0201061.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/056d/6053230/e66e8eefd353/pone.0201061.g002.jpg

相似文献

1
Ischemic stroke risk during long-term follow up in patients with successful catheter ablation for atrial fibrillation in Korea.韩国成功行导管消融术治疗心房颤动患者的长期随访期间的缺血性卒中风险。
PLoS One. 2018 Jul 19;13(7):e0201061. doi: 10.1371/journal.pone.0201061. eCollection 2018.
2
Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.肾功能障碍、卒中风险评分(CHADS2、CHA2DS2-VASc 和 R2CHADS2)与心房颤动导管消融术后血栓栓塞事件风险:莱比锡心脏中心房颤消融登记研究。
Circ Arrhythm Electrophysiol. 2013 Oct;6(5):868-74. doi: 10.1161/CIRCEP.113.000869. Epub 2013 Sep 18.
3
CHADS-VASc Score (Congestive Heart Failure, Hypertension, Age ≥75 [Doubled], Diabetes Mellitus, Prior Stroke or Transient Ischemic Attack [Doubled], Vascular Disease, Age 65-74, Female) for Stroke in Asian Patients With Atrial Fibrillation: A Korean Nationwide Sample Cohort Study.亚洲房颤患者卒中的CHADS-VASc评分(充血性心力衰竭、高血压、年龄≥75岁[加倍]、糖尿病、既往卒中或短暂性脑缺血发作[加倍]、血管疾病、年龄65 - 74岁、女性):一项韩国全国性样本队列研究。
Stroke. 2017 Jun;48(6):1524-1530. doi: 10.1161/STROKEAHA.117.016926. Epub 2017 Apr 28.
4
The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.风险评分(CHADS2与CHA2DS2-VASc)对心房颤动消融术后长期预后的影响。
Heart Rhythm. 2015 Apr;12(4):681-6. doi: 10.1016/j.hrthm.2014.12.034. Epub 2014 Dec 26.
5
Additional value of left atrial appendage geometry and hemodynamics when considering anticoagulation strategy in patients with atrial fibrillation with low CHADS-VASc scores.在考虑低 CHADS-VASc 评分的房颤患者抗凝策略时,左心耳形态和血流动力学的附加价值。
Heart Rhythm. 2017 Sep;14(9):1297-1301. doi: 10.1016/j.hrthm.2017.05.034. Epub 2017 May 27.
6
Comparison of CHADS2, R2CHADS2, and CHA2DS2-VASc scores for the prediction of rhythm outcomes after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.比较 CHADS2、R2CHADS2 和 CHA2DS2-VASc 评分在预测心房颤动导管消融后节律转归中的作用:莱比锡心脏中心房颤消融登记研究。
Circ Arrhythm Electrophysiol. 2014 Apr;7(2):281-7. doi: 10.1161/CIRCEP.113.001182. Epub 2014 Mar 8.
7
Stroke prediction with CHADS-VASc score in patients with mesenteric ischemia without atrial fibrillation-insights from a nationwide cohort.无房颤的肠系膜缺血患者中CHADS-VASc评分对卒中的预测——来自一项全国性队列研究的见解
J Clin Neurosci. 2017 Nov;45:193-198. doi: 10.1016/j.jocn.2017.06.007. Epub 2017 Jul 3.
8
Incidence and prediction of ischemic stroke among atrial fibrillation patients with end-stage renal disease requiring dialysis.需要透析的终末期肾病房颤患者缺血性卒中的发病率及预测
Heart Rhythm. 2014 Oct;11(10):1752-9. doi: 10.1016/j.hrthm.2014.06.021. Epub 2014 Jun 18.
9
CHA₂DS₂-VASc Score in the Prediction of Ischemic Stroke in Patients after Radiofrequency Catheter Ablation of Typical Atrial Flutter.CHA₂DS₂-VASc评分在典型心房扑动射频导管消融术后患者缺血性卒中预测中的应用
Yonsei Med J. 2018 Mar;59(2):236-242. doi: 10.3349/ymj.2018.59.2.236.
10
CHADS-VASc Score for Identifying Truly Low-Risk Atrial Fibrillation for Stroke: A Korean Nationwide Cohort Study.用于识别真正低风险房颤卒中的CHADS-VASc评分:一项韩国全国性队列研究
Stroke. 2017 Nov;48(11):2984-2990. doi: 10.1161/STROKEAHA.117.018551. Epub 2017 Sep 22.

引用本文的文献

1
Freedom from atrial arrhythmia and other clinical outcomes at 5 years and beyond after catheter ablation of atrial fibrillation: a systematic review and meta-analysis.导管消融心房颤动 5 年及以上后无房性心律失常和其他临床结局:系统评价和荟萃分析。
Eur Heart J Qual Care Clin Outcomes. 2023 Aug 7;9(5):447-458. doi: 10.1093/ehjqcco/qcad037.

本文引用的文献

1
Risk of Stroke and Recurrence After AF Ablation in Patients With an Initial Event-Free Period of 12 Months.初始无事件期为12个月的房颤消融术后患者的卒中风险及复发情况
J Cardiovasc Electrophysiol. 2017 Mar;28(3):273-279. doi: 10.1111/jce.13138. Epub 2017 Jan 11.
2
Catheter ablation for atrial fibrillation is associated with lower incidence of stroke and death: data from Swedish health registries.导管消融治疗心房颤动与较低的卒中和死亡率相关:来自瑞典健康登记处的数据。
Eur Heart J. 2016 Aug;37(31):2478-87. doi: 10.1093/eurheartj/ehw087. Epub 2016 Mar 16.
3
Oral anticoagulant therapy for stroke prevention in patients with atrial fibrillation undergoing ablation: results from the First European Snapshot Survey on Procedural Routines for Atrial Fibrillation Ablation (ESS-PRAFA).
用于接受消融治疗的心房颤动患者预防卒中的口服抗凝治疗:来自首届欧洲心房颤动消融手术流程快照调查(ESS-PRAFA)的结果
Europace. 2015 Jun;17(6):986-93. doi: 10.1093/europace/euv132.
4
Catheter Ablation of Atrial Fibrillation in U.S. Community Practice--Results From Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).美国社区医疗实践中房颤的导管消融术——房颤更优知情治疗结局注册研究(ORBIT-AF)的结果
J Am Heart Assoc. 2015 May 21;4(5):e001901. doi: 10.1161/JAHA.115.001901.
5
Radiofrequency ablation vs. antiarrhythmic drug therapy as first line treatment of symptomatic atrial fibrillation: systematic review and meta-analysis.射频消融术与抗心律失常药物治疗作为症状性心房颤动一线治疗的比较:系统评价与荟萃分析
Europace. 2015 Mar;17(3):370-8. doi: 10.1093/europace/euu376. Epub 2015 Feb 1.
6
Oral anticoagulation therapy after radiofrequency ablation of atrial fibrillation and the risk of thromboembolism and serious bleeding: long-term follow-up in nationwide cohort of Denmark.房颤射频消融术后的口服抗凝治疗与血栓栓塞和严重出血的风险:丹麦全国队列的长期随访。
Eur Heart J. 2015 Feb 1;36(5):307-14a. doi: 10.1093/eurheartj/ehu421. Epub 2014 Nov 3.
7
2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.2014年美国心脏协会/美国心脏病学会/心律学会心房颤动患者管理指南:美国心脏病学会/美国心脏协会实践指南工作组及心律学会的报告
J Am Coll Cardiol. 2014 Dec 2;64(21):e1-76. doi: 10.1016/j.jacc.2014.03.022. Epub 2014 Mar 28.
8
Discerning the incidence of symptomatic and asymptomatic episodes of atrial fibrillation before and after catheter ablation (DISCERN AF): a prospective, multicenter study.在导管消融前后辨别有症状和无症状的心房颤动发作(DISCERN AF):一项前瞻性、多中心研究。
JAMA Intern Med. 2013 Jan 28;173(2):149-56. doi: 10.1001/jamainternmed.2013.1561.
9
Use of the CHA(2)DS(2)-VASc and HAS-BLED scores to aid decision making for thromboprophylaxis in nonvalvular atrial fibrillation.使用CHA(2)DS(2)-VASc评分和HAS-BLED评分辅助非瓣膜性心房颤动患者血栓预防的决策制定。
Circulation. 2012 Aug 14;126(7):860-5. doi: 10.1161/CIRCULATIONAHA.111.060061.
10
Very low risk of thromboembolic events in patients undergoing successful catheter ablation of atrial fibrillation with a CHADS2 score ≤3: a long-term outcome study.在 CHADS2 评分≤3 的房颤患者中,成功接受导管消融治疗后发生血栓栓塞事件的风险非常低:一项长期预后研究。
Circ Arrhythm Electrophysiol. 2011 Oct;4(5):615-21. doi: 10.1161/CIRCEP.111.963231. Epub 2011 Aug 13.